Alignment Healthcare (ALHC) to Release Quarterly Earnings on Thursday

Alignment Healthcare (NASDAQ:ALHC) will announce its earnings results after the market closes on Thursday, August 1st. Analysts expect the company to announce earnings of ($0.14) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, May 2nd. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.01). The company had revenue of $628.60 million for the quarter, compared to the consensus estimate of $599.75 million. Alignment Healthcare had a negative return on equity of 91.06% and a negative net margin of 7.81%. The firm’s quarterly revenue was up 43.1% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.20) earnings per share. On average, analysts expect Alignment Healthcare to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Alignment Healthcare Trading Up 2.3 %

Alignment Healthcare stock opened at $8.76 on Wednesday. Alignment Healthcare has a 12-month low of $4.46 and a 12-month high of $10.16. The company has a debt-to-equity ratio of 1.23, a current ratio of 1.57 and a quick ratio of 1.57. The stock has a market capitalization of $1.67 billion, a PE ratio of -10.43 and a beta of 1.43. The firm has a 50 day simple moving average of $8.21 and a 200-day simple moving average of $6.72.

Insider Buying and Selling at Alignment Healthcare

In other news, CFO Robert Thomas Freeman sold 38,858 shares of the business’s stock in a transaction that occurred on Friday, July 19th. The shares were sold at an average price of $10.01, for a total transaction of $388,968.58. Following the sale, the chief financial officer now owns 414,429 shares in the company, valued at $4,148,434.29. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, CFO Robert Thomas Freeman sold 38,858 shares of Alignment Healthcare stock in a transaction on Friday, July 19th. The stock was sold at an average price of $10.01, for a total transaction of $388,968.58. Following the transaction, the chief financial officer now owns 414,429 shares in the company, valued at $4,148,434.29. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Dawn Christine Maroney sold 36,700 shares of the company’s stock in a transaction on Friday, July 19th. The shares were sold at an average price of $10.01, for a total value of $367,367.00. Following the transaction, the insider now directly owns 1,816,097 shares in the company, valued at $18,179,130.97. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 225,221 shares of company stock valued at $2,142,155. 6.60% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

ALHC has been the subject of a number of research reports. Stephens increased their price target on Alignment Healthcare from $6.00 to $7.00 and gave the company an “equal weight” rating in a research note on Friday, May 3rd. Bank of America raised Alignment Healthcare from a “neutral” rating to a “buy” rating and raised their target price for the company from $7.75 to $11.00 in a research note on Thursday, May 30th. Baird R W upgraded shares of Alignment Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Robert W. Baird initiated coverage on shares of Alignment Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $10.00 price objective for the company. Finally, Stifel Nicolaus boosted their target price on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a “buy” rating in a report on Friday, July 26th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, six have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $9.44.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.